These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 26721937)

  • 1. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.
    Severs M; van Erp SJ; van der Valk ME; Mangen MJ; Fidder HH; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Bolwerk C; Vermeijden JR; Pierik MJ; Siersema PD; Leenders M; van der Meulen-de Jong AE; Dijkstra G; Oldenburg B;
    J Crohns Colitis; 2016 Apr; 10(4):455-61. PubMed ID: 26721937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.
    Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S
    Digestion; 2014; 90(2):122-9. PubMed ID: 25277851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
    Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
    Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beliefs and behaviour about smoking among inflammatory bowel disease patients.
    Saadoune N; Peyrin-Biroulet L; Baumann C; Bigard MA; Wirth N; Martinet Y; Peyrin-Biroulet C
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):797-803. PubMed ID: 25919776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
    Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
    United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
    Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A;
    Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Li JX; Chiang CC; Chen SN; Lin JM; Tsai YY
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of smoking cessation in patients with inflammatory bowel disease.
    González-Muñoza C; Gely C; Gordillo J; Bertoletti F; Giordano A; López-Faba A; García-Planella E
    Gastroenterol Hepatol; 2024; 47(6):591-597. PubMed ID: 37977427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
    Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
    [No Abstract]   [Full Text] [Related]  

  • 16. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
    Ott C; Takses A; Obermeier F; Schnoy E; Müller M
    World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.
    Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP
    J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
    Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
    World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease in Iran: a review of 457 cases.
    Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.